Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WJ22096 in Advanced Solid Tumors
NCT07253116Phase 2Recruiting
- Sponsor
- Nanjing Jingao Biomedical Technology Co., Ltd.
- Start
- Nov 2025
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WJ22096 in solid tumor (advanced stage), non-small cell lung cancer (NSCLC), colorectal cancer (CRC), pancreatic cancer (PC), sponsored by Nanjing Jingao Biomedical Technology Co., Ltd.. Started Nov 2025; status: recruiting.
02
Drugs
WJ22096
03
Conditions
solid tumor (advanced stage)non-small cell lung cancer (NSCLC)colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07253116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07253116.